Abstract

BackgroundOur previous studies showed the expression of herpes virus entry mediator (HVEM) is high in ovarian cancer samples and correlated to the patient clinic pathological features. As we all know, the hypoxic environment is the main feature of tumor. In this work, we explored the role of HVEM in hypoxic ovarian cancer cells and its effects on HIF-1α, a transcription factor responding to hypoxia.MethodsThe expression of HVEM, HIF-1α and apoptosis-related genes was detected by qRT-PCR and western blot. The proliferation and apoptosis of the ovarian cancer cells were determined with the Cell Counting Kit-8 assay and AnnexinV-FITC/PI-stained flow cytometry assay, respectively.ResultsThe expression of HVEM was positively correlated to that of HIF-1α. The expression of HVEM and HIF-1α under hypoxic conditions was higher than that under normoxic conditions, which suggested that the level of HVEM and HIF-1α correlates with prolonged periods of hypoxia in ovarian cancer. The overexpression of HVEM promoted cell proliferation and inhibited cell apoptosis under hypoxic condition. HVEM overexpression elevated the expression of HIF-1α and Bcl-2 (anti-apoptotic protein), and reduced the expression of Bax (pro-apoptotic protein). In addition, overexpression of HVEM activated the AKT/mTOR signaling. Moreover, knockdown of HVEM had the completely opposite effects.ConclusionThese data indicated that HVEM signaling might promote HIF-1α activity via AKT/mTOR signaling pathway and thus to regulate tumor growth in ovarian cancer under the hypoxic conditions. Furthermore, these findings indicate that this molecular mechanism could represent a therapeutic target for ovarian cancer.

Highlights

  • Ovarian cancer is the most commonly diagnosed malignant gynecological tumor and the primary cause of tumor-related mortality for genital system

  • herpes virus entry mediator (HVEM) co-expressed with HIF-1α in patients with ovarian cancer In our previous study, HVEM was found highly expressed in the ovarian cancer tissues compared with normal tissues [18]

  • HVEM was correlated to TNM stage, lymph node metastasis and recurrence in ovarian serous adenocarcinoma [17]

Read more

Summary

Introduction

Ovarian cancer is the most commonly diagnosed malignant gynecological tumor and the primary cause of tumor-related mortality for genital system. In United States, total 22,240 new cases and 14,070 deaths of ovary in situ, accounting for 2.5% of all estimated new cases and 4.9% of all estimated deaths among female, were estimated in 2018 [2]. Ovarian cancer was commonly treated with surgery, chemotherapy, and radiotherapy, which can alleviate some symptoms. These treatments seriously affect the quality of patient life and the recurrence rate is still high. The poor prognoses of ovarian cancer patients are related to chemotherapy resistance and tumor metastasis [4]. Our previous studies showed the expression of herpes virus entry mediator (HVEM) is high in ovarian cancer samples and correlated to the patient clinic pathological features. We explored the role of HVEM in hypoxic ovarian cancer cells and its effects on HIF-1α, a transcription factor responding to hypoxia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call